Mesoblast's market cap is currently $2.23B. The company's EPS TTM is $-0.889; its P/E ratio is ―; Mesoblast is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	$ 5.90M	$ 7.50M	$ 10.21M	$ 7.46M	$ 32.16M
Gross Profit	$ -35.17M	$ -20.23M	$ -20.55M	$ -25.26M	$ 6.85M
Operating Income	$ -84.15M	$ -69.14M	$ -80.95M	$ -111.87M	$ -79.07M
EBITDA	$ -56.08M	$ -61.38M	$ -69.92M	$ -79.43M	$ -68.97M
Net Income	$ -87.96M	$ -81.89M	$ -91.35M	$ -98.81M	$ -77.94M
Balance Sheet
Cash & Short-Term Investments	$ 62.56M	$ 70.92M	$ 60.03M	$ 136.88M	$ 129.33M
Total Assets	$ 669.15M	$ 669.41M	$ 662.14M	$ 744.72M	$ 733.60M
Total Debt	$ 118.92M	$ 116.50M	$ 106.91M	$ 105.50M	$ 99.31M
Net Debt	$ 56.36M	$ 45.58M	$ 46.87M	$ -31.39M	$ -30.01M
Total Liabilities	$ 188.80M	$ 167.58M	$ 165.10M	$ 163.32M	$ 184.28M
Stockholders' Equity	$ 480.36M	$ 501.84M	$ 497.04M	$ 581.40M	$ 549.33M
Cash Flow
Free Cash Flow	$ -48.79M	$ -63.58M	$ -66.01M	$ -108.33M	$ -58.61M
Operating Cash Flow	$ -48.46M	$ -63.27M	$ -65.78M	$ -106.68M	$ -56.37M
Investing Cash Flow	$ -97.00K	$ -194.00K	$ -232.00K	$ -1.65M	$ -3.27M
Financing Cash Flow	$ 40.25M	$ 74.50M	$ -9.87M	$ 114.47M	$ 137.04M

Currency in USD

Mesoblast Earnings and Revenue History

Income Statement >

Mesoblast Debt to Assets

Balance Sheet >

Mesoblast Cash Flow

Cash Flow >

Mesoblast Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing